BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 02:35 pm
Intimation of Trading Window closure for quarter and half year ending September 30, 2026
Kimia Biosciences Ltd · 530313
✦ AI SummaryResults
Kimia Biosciences Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kimia Biosciences Ltd - 530313 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
99b41d80-8a21-4a0b-b9f2-5e39de3892d4.pdf
View document text
BSE Limited Ref: KIMIABL/COMP/BSE/2026-27
Corporate Relationship Department Date: 26 September 2026
Phiroze Jeejeebhoy Towers
Dalal Street, Mumbai – 400001
Scrip Code: 530313
Security ID: KIMIABL
Subject: Intimation of Closure of Trading Window
Dear Sir/Madam,
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations,
2015, as amended, read with the Company's Code of Conduct for Regulating,
Monitoring and Reporting of Trading by Designated Persons, we hereby inform you
that the Trading Window for dealing in the equity shares of the Company shall remain
closed with effect from 1 October 2026 till the expiry of 48 (Forty-Eight) hours after
the declaration of the Unaudited Financial Results of the Company for the quarter and
half-year ended 30 September 2026.
Accordingly, the Trading Window shall remain closed for all Promoters, Members of the
Promoter Group, Directors, Designated Persons of the Company and their Immediate
Relatives, and other persons covered under the Company's Code of Conduct.
The date of the meeting of the Board of Directors for consideration and approval of the
aforesaid financial results shall be intimated separately in due course in accordance
with the applicable provisions of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
You are requested to kindly take the above information on record.
Thanking you,
For Kimia Biosciences Limited
Abhishek K. Pandey
Company Secretary & Compliance Officer
Membership No.: F12457
Place: Delhi
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120